Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
12.4M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
17.4M
-
Shares change
-
-2.72M
-
Total reported value, excl. options
-
$2.87M
-
Value change
-
-$506K
-
Number of buys
-
12
-
Number of sells
-
-16
-
Price
-
$0.16
Significant Holders of P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) as of Q1 2025
42 filings reported holding PIII - P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2025.
P3 Health Partners Inc. - Class A Common Stock, par value $0.0001 per share (PIII) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.4M shares
.
Largest 10 shareholders include Alyeska Investment Group, L.P. (9.05M shares), Corient Private Wealth LLC (1.87M shares), VANGUARD GROUP INC (1.82M shares), Trinity Financial Advisors LLC (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (980K shares), RENAISSANCE TECHNOLOGIES LLC (406K shares), Abundance Wealth Counselors (400K shares), BlackRock, Inc. (382K shares), UBS Group AG (236K shares), and Cresset Asset Management, LLC (200K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.